Cargando...
Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients
BACKGROUND: Secondary hyperparathyroidism (SHPT) is a serious and common complication in patients receiving peritoneal dialysis (PD). Cinacalcet is currently the recommended therapy for SHPT; however, gastrointestinal (GI)-related symptoms can result in low adherence and high discontinuation rates....
Guardado en:
| Publicado en: | Clin Exp Nephrol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Singapore
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6586709/ https://ncbi.nlm.nih.gov/pubmed/30955188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-019-01692-y |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|